Download:
pdf |
pdfIntroduction
Form Approved
OMB No. 09200864
Exp. Date 9/30/2013
Other
Web Based Survey Instrument to Assess Adoption and Use of the IOM Report on Hypertension
Thank you for agreeing to complete this survey about the Institute of Medicine (IOM) report “Public Health Priorities to
Reduce and Control Hypertension in the U.S. Population” published in February 2010. The results of this survey will
be used to assess how the Division for Heart Disease and Stroke Prevention (DHDSP) at the Centers for Disease Control
and Prevention (CDC) can best support state heart disease and stroke prevention programs in implementing strategies for
reducing and controlling hypertension, and to understand states' progress in implementing the IOM recommendations.
Please respond to the questions from the perspective of your role as your state’s (or other entity's) Heart Disease and
Stroke Prevention (HDSP) program manager.
Please note that the focus and purpose of this survey are entirely different from those of the survey on “Assessing State
Programs’ CommunityClinical Linkage Strategies.”
Public reporting burden of this collection of information is estimated to average 25 minutes per response, including the
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not
required to respond to a collection of information unless it displays a currently valid OMB control number. Send
comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for
reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS D74, Atlanta, Georgia 30333;
ATTN: PRA (09200864).
Consent Statement
Battelle, a CDC contractor, is conducting a web based survey as part of the evaluation of the DHDSP’s initiatives to
reduce and control hypertension. The purpose of this survey is to obtain feedback on DHDPS’s technical assistance and
other resources provided to health department staff of states and other entities to help them implement the
recommendations in the IOM Report. You were chosen to participate in this survey because you are a program manager
in a heart disease and stroke prevention program. We encourage you to consult with other program staff as needed to
provide accurate responses. The survey should take no more than 25 minutes of your time.
Participation in the survey is voluntary; you may choose to end the survey at any time for any reason with no penalty.
Some questions require responses to determine which followup questions will appear. Questions requiring responses
are marked with asterisks (*). Your participation in the survey poses few, if any risks to you.
You will be given the opportunity to identify your state/entity at the end of the survey. This approach allows us to link to
information already provided in your periodic reporting to DHDSP rather than requesting that it be supplied again here. In
addition, you may choose to request the opportunity to participate in a voluntary discussion with one of our project staff
members to further elaborate your experiences and technical assistance needs.
If you have any questions about this survey, or evaluation, please contact Dr. Judith Berkowitz at Battelle at Phone: (404)
4601449, Email: Berkowitzj@battelle.org
By clicking “Next” you give your consent to participate in this survey.
1. How long have you been associated with the state/entity HDSP program?
j Less than 1 year
k
l
m
n
j 1 to less than 2 years
k
l
m
n
j 2 to less than 5 years
k
l
m
n
j 5 or more years
k
l
m
n
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*2. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Other
Recommendation 6.1: SLHJ should give priority to populationbased approaches over
individualbased approaches to prevent and control hypertension.
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.1: SLHJ should give priority to populationbased approaches over individualbased
approaches to prevent and control hypertension.
3. To what extent did the IOM report influence your decision to take action on this
recommendation?
Additional
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
j A great extent
k
l
m
n
4. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
5. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
6. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters.)
Other
Recommendation 6.1: SLHJ should give priority to populationbased approaches over individualbased
approaches to prevent and control hypertension.
7. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
Additional
pressure, Cholesterol,
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
8. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
9. What materials do you need from DHDSP to make further progress on implementing this
recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
Other
c Additional guidance materials (please specify)
d
e
f
g
10. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.1: SLHJ should give priority to populationbased approaches over individualbased
approaches to prevent and control hypertension.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
11. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
12. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*13. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Recommendation 6.2: SLHJ should integrate hypertension prevention and control in
programmatic
efforts to effect system, environmental, and policy changes that will support
Other
healthy eating, active living, and obesity prevention.
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.2: SLHJ should integrate hypertension prevention and control in programmatic efforts to
effect system, environmental, and policy changes that will support healthy eating, active living, and obesity
prevention.
14. To what extent did the IOM report influence your decision to take action on this
recommendation?
Additional
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
j A great extent
k
l
m
n
15. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
16. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
17. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this
Other recommendation in your state/entity. (Answers should not exceed 600 characters.)
Recommendation 6.2: SLHJ should integrate hypertension prevention and control in programmatic efforts to
effect system, environmental, and policy changes that will support healthy eating, active living, and obesity
prevention.
18. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
Additional
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
19. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
20. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
Other
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Additional guidance materials (please specify)
d
e
f
g
21. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.2: SLHJ should integrate hypertension prevention and control in programmatic efforts to
effect system, environmental, and policy changes that will support healthy eating, active living, and obesity
prevention.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
22. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
23. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*24. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Other
Recommendation 6.3: SLHJ jurisdictions should immediately begin to consider
developing a portfolio of dietary sodium reduction strategies that make the most sense for
early action in their jurisdiction.
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.3: SLHJ jurisdictions should immediately begin to consider developing a portfolio of
dietary sodium reduction strategies that make the most sense for early action in their jurisdiction.
25. To what extent did the IOM report influence your decision to take action on this
Additional
recommendation?
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
j A great extent
k
l
m
n
26. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
27. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
Other
28.
In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters).
Recommendation 6.3: SLHJ jurisdictions should immediately begin to consider developing a portfolio of
dietary sodium reduction strategies that make the most sense for early action in their jurisdiction.
29. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
Additional
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
30. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
31. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
Other
c Additional guidance materials (please specify)
d
e
f
g
32. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.3: SLHJ jurisdictions should immediately begin to consider developing a portfolio of
dietary sodium reduction strategies that make the most sense for early action in their jurisdiction.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
33. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
34. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*35. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Recommendation 6.4: SLHJ should assess their capacity to develop local HANES as a
means to obtain local estimates of the prevalence, awareness, treatment and control of
hypertension.
Other
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.4: SLHJ should assess their capacity to develop local HANES as a means to obtain local
estimates of the prevalence, awareness, treatment and control of hypertension.
36. To what extent did the IOM report influence your decision to take action on this
recommendation?
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
Additional
j A great extent
k
l
m
n
37. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
38. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
39. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters.)
Other
Recommendation 6.4: SLHJ should assess their capacity to develop local HANES as a means to obtain local
estimates of the prevalence, awareness, treatment and control of hypertension.
40. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Additional
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
41. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
42. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Additional guidance materials (please specify)
d
e
f
g
Other
43.
What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.4: SLHJ should assess their capacity to develop local HANES as a means to obtain local
estimates of the prevalence, awareness, treatment and control of hypertension.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
44. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
45. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*46. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Recommendation 6.5: SLHJ should serve as conveners of health care system
representatives, physician groups, purchasers of health care services, quality
improvement organizations, and employers (and others) to develop a plan to engage, and
leverage skills and resources for improving the medical treatment of hypertension.
j Yes
k
l
m
n
j No
k
l
m
n
Other
j Don't Know
k
l
m
n
Recommendation 6.5: SLHJ should serve as conveners of health care system representatives, physician
groups, purchasers of health care services, quality improvement organizations, and employers (and others) to
develop a plan to engage, and leverage skills and resources for improving the medical treatment of
hypertension.
47. To what extent did the IOM report influence your decision to take action on this
recommendation?
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
Additional
j A great extent
k
l
m
n
48. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
49. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
50. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters.)
Other
Recommendation 6.5: SLHJ should serve as conveners of health care system representatives, physician
groups, purchasers of health care services, quality improvement organizations, and employers (and others) to
develop a plan to engage, and leverage skills and resources for improving the medical treatment of
hypertension.
51. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Smoking)
Additional
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
52. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
53. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Additional guidance materials (please specify)
d
e
f
g
Other
54. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.5: SLHJ should serve as conveners of health care system representatives, physician
groups, purchasers of health care services, quality improvement organizations, and employers (and others) to
develop a plan to engage, and leverage skills and resources for improving the medical treatment of
hypertension.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
55. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
56. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*57. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Recommendation 6.6: SLHJ should work with business coalitions and purchasing
coalitions to remove economic barriers to effective antihypertensive medications for
individuals who have difficulty accessing them.
Other
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.6: SLHJ should work with business coalitions and purchasing coalitions to remove
economic barriers to effective antihypertensive medications for individuals who have difficulty accessing
them.
58. To what extent did the IOM report influence your decision to take action on this
recommendation?
j Not at all
k
l
m
n
Additional
j Somewhat
k
l
m
n
j A great extent
k
l
m
n
59. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
60. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
61. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters.)
Other
Recommendation 6.6: SLHJ should work with business coalitions and purchasing coalitions to remove
economic barriers to effective antihypertensive medications for individuals who have difficulty accessing
them.
62. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Additional
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
63. What training or technical assistance do you need from DHDSP to make further
Other
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
64. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
Other
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Additional guidance materials (please specify)
d
e
f
g
65. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.6: SLHJ should work with business coalitions and purchasing coalitions to remove
economic barriers to effective antihypertensive medications for individuals who have difficulty accessing
them.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
66. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
67. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
In all of the following questions “IOM report” refers to the IOM report "Public Health Priorities to Reduce and Control
Hypertension in the U.S. Population" released in February 2010. Seven of the recommendations in the IOM report were
directed to State and Local Health Jurisdictions (SLHJs). Those specific recommendations are referenced throughout this
survey.
*68. Which of the 7 statefocused IOM recommendations have you decided to take action
on since the release of the IOM report in February 2010?
Recommendation 6.7: SLHJ should promote and work with community health worker
initiatives to ensure that prevention and control of hypertension is included in the array of
services they provide and are appropriately linked to primary care services.
j Yes
k
l
m
n
j No
k
l
m
n
j Don't Know
k
l
m
n
Recommendation 6.7: SLHJ should promote and work with community health worker initiatives to ensure that
prevention and control of hypertension is included in the array of services they provide and are appropriately
linked to primary care services.
69. To what extent did the IOM report influence your decision to take action on this
recommendation?
j Not at all
k
l
m
n
j Somewhat
k
l
m
n
j A great extent
k
l
m
n
70. Which of the following factors influenced your decision to take action? Check all that
apply.
c CDC focus on ABCS (aspirin, blood pressure, cholesterol, smoking)
d
e
f
g
c Current work in this area by state/entity health department
d
e
f
g
c Capacity of state/entity health department (e.g. program staff expertise, internal health department partners and resources)
d
e
f
g
c Support from external partners ( expertise and resources)
d
e
f
g
c State or entitylevel surveillance data availability
d
e
f
g
c Other (please specify)
d
e
f
g
71. How far along are you in implementing this recommendation?
j Have not yet begun
k
l
m
n
j Planning for implementation
k
l
m
n
j In process of implementing
k
l
m
n
j Implementation currently stalled
k
l
m
n
j Fully implemented as planned
k
l
m
n
72. In 2 or 3 sentences, please describe what you did, or are planning to do, to implement
this recommendation in your state/entity. (Answers should not exceed 600 characters.)
Recommendation 6.7: SLHJ should promote and work with community health worker initiatives to ensure that
prevention and control of hypertension is included in the array of services they provide and are appropriately
linked to primary care services.
73. Please indicate the resources you used to support your implementation of this
recommendation? Check all that apply. Please rate the usefulness of each resource that
you used in supporting your implementation of this recommendation.
DHDSP guidance materials
Did Not Use
Very Useful
Somewhat Useful
Not At All Useful
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
j
k
l
m
n
on ABCS (Aspirin, Blood
pressure, Cholesterol,
Smoking)
CVH Council Resources
(e.g. Meaningful Use,
Academic Detailing,
Community Health Worker)
CVH Council Practice
Groups (e.g. Sodium,
Community Based Non
Physician Providers, Stroke
Systems of Care, Physician
Adherence)
Technical assistance from
DHDSP Project Officers
DHDSP Practitioner
Trainings
Support of external partners
(external expertise and
resources)
Other (please specify
below)
Specify (if indicated use of "Other" above)
74. What training or technical assistance do you need from DHDSP to make further
progress on implementing this recommendation? Check all that apply.
c Developing an action plan to implement the recommendation
d
e
f
g
c Evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Translating hypertension strategies and evidencebased practices
d
e
f
g
c Facilitating opportunities to network with other states/entities implementing this recommendation
d
e
f
g
c Other (please specify)
d
e
f
g
75. What materials do you need from DHDSP to make further progress on implementing
this recommendation? Check all that apply.
c Written directives from CDC
d
e
f
g
c Communication materials such as policy statements and press releases
d
e
f
g
c Written and webbased materials related to hypertension control and treatment
d
e
f
g
c Translation of evidencebased practices
d
e
f
g
c Examples of practicebased evidence
d
e
f
g
c Success stories from other state/entity experiences
d
e
f
g
c Guidance on evaluating progress in implementing recommendations and outcomes
d
e
f
g
c Additional guidance materials (please specify)
d
e
f
g
76. What outcomes, if any, have you seen/do you expect to see from implementing this
recommendation? (Answers should not exceed 600 characters.)
Recommendation 6.7: SLHJ should promote and work with community health worker initiatives to ensure that
prevention and control of hypertension is included in the array of services they provide and are appropriately
linked to primary care services.
You indicated above that you have not taken action on this recommendation; we are interested in learning more about
why you have not. Please refer to the following questions.
77. Which of the following factors influenced your decision not to take action on this
recommendation? Check all that apply.
c Did not view the recommended action as a need
d
e
f
g
c Recommendation is outside scope of state/entity HDSP goals
d
e
f
g
c Recommendation competes/conflicts with other HDSP priorities
d
e
f
g
c Lack of technical assistance/support in the area
d
e
f
g
c Internal health department capacity was not adequate at this time (e.g. program staff expertise, internal health department partners and
d
e
f
g
resources)
c External partner support was not adequate at this time (external expertise and resources)
d
e
f
g
c Lack of state or entitylevel surveillance data
d
e
f
g
c Other (please specify)
d
e
f
g
78. What would you need from DHDSP in order to be able to implement this
recommendation in your state/entity? Check all that apply.
c Further directive from CDC
d
e
f
g
c Assistance with developing an action plan to implement the recommendation
d
e
f
g
c Oneonone technical assistance from DHDSP project officers
d
e
f
g
c Increased networking with other states/entities implementing this recommendation
d
e
f
g
c Guidance on translation of evidencebased practices
d
e
f
g
c Additional guidance materials or other support (please specify in the area below)
d
e
f
g
79. Sodium intake and its relationship with heart disease and stroke prevention were a
focus in the IOM report. We are interested in knowing what types of surveillance activities
about sodium intake may be ongoing.
What types of sodiumrelated surveillance activities is your state/entity currently
implementing? Please check all that apply.
c We are currently using the BRFSS sodium module of 3 questions
d
e
f
g
c We are currently using 12 questions from the BRFSS sodium module
d
e
f
g
c We plan to implement the BRFSS sodium module but have not at present
d
e
f
g
c We are using other sodium related questions (not from the BRFSS module)
d
e
f
g
c We plan to have an activity, just not in BRFSS
d
e
f
g
c We do not plan to conduct sodium intake surveillance
d
e
f
g
c Other (please specify)
d
e
f
g
80. What would you need from CDC in order to conduct sodium intake surveillance?
Please check all that apply.
c No support or assistance needed at this time
d
e
f
g
c Technical assistance with the BRFSS sodium module
d
e
f
g
c Technical assistance developing nonBRFSS sodium questions
d
e
f
g
c Training on sodium
d
e
f
g
c Training on BRFSS
d
e
f
g
c Funding or other resources
d
e
f
g
c Other (please specify)
d
e
f
g
81. Is there anything we haven't asked you that would be good for us to know related to
the topic of this IOM report or its recommendations?
5
6
*82. For which state/entity are you responding? Please select from the list below.
(OPTIONAL.)
6
83. We would like to contact some state/entity representatives for followup discussions
about the challenges and success factors in implementing the IOM Recommendations? If
you are willing to be contacted for further discussion, please provide your contact
information.
Name:
Email Address:
We thank you for your time. If you have questions about this survey please contact Dr. Judith Berkowitz at:
Phone: (404) 4601449,
Email: berkowitzj@battelle.org.
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |